首页|脓毒症相关凝血功能障碍机制和生物标志物及治疗研究新进展

脓毒症相关凝血功能障碍机制和生物标志物及治疗研究新进展

扫码查看
脓毒症是一种由感染触发的全身炎症反应综合征,也是导致危重症患者死亡的主要因素之一。脓毒症引发的凝血功能障碍不仅是威胁生命的一种并发症,也是脓毒症患者病情恶化的关键因素。因此,深入研究脓毒症凝血功能障碍的机制和相关的生物标志物,将有助于临床医师更早地识别这些问题,从而改善患者的预后情况,并为临床医师提供新的治疗方向。
Research progress on mechanisms,biomarkers and treatment of sepsis-associated coagulopathy
Sepsis is a systemic inflammatory response syndrome triggered by infection,and it is also one of the main factors leading to the death of critically ill patients.Coagulopathy caused by sepsis is not only a life-threatening complication,but also a key factor for the deterioration of patients with sepsis.Therefore,in-depth study of the mechanism of sepsis coagulopathy and related biomarkers will help clinicians to identify these problems earlier,so as to improve the prognosis of patients and provide clinicians with new treatment directions.

SepsisCoagulopathyMechanismsBiomarkersTreatment

娜孜拉·海热提、何勇波、杨建中

展开 >

新疆医科大学第一附属医院急诊科,乌鲁木齐 830011

脓毒症 凝血功能障碍 机制 生物标志物 治疗

2025

中国医药
中华医学会

中国医药

影响因子:1.356
ISSN:1673-4777
年,卷(期):2025.20(1)